1. Home
  2. ADMA vs PIPR Comparison

ADMA vs PIPR Comparison

Compare ADMA & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • PIPR
  • Stock Information
  • Founded
  • ADMA 2004
  • PIPR 1895
  • Country
  • ADMA United States
  • PIPR United States
  • Employees
  • ADMA N/A
  • PIPR N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • PIPR Investment Bankers/Brokers/Service
  • Sector
  • ADMA Health Care
  • PIPR Finance
  • Exchange
  • ADMA Nasdaq
  • PIPR Nasdaq
  • Market Cap
  • ADMA 4.1B
  • PIPR 4.9B
  • IPO Year
  • ADMA N/A
  • PIPR N/A
  • Fundamental
  • Price
  • ADMA $17.91
  • PIPR $252.56
  • Analyst Decision
  • ADMA Strong Buy
  • PIPR Hold
  • Analyst Count
  • ADMA 4
  • PIPR 3
  • Target Price
  • ADMA $22.50
  • PIPR $330.00
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • PIPR 140.1K
  • Earning Date
  • ADMA 03-03-2025
  • PIPR 04-25-2025
  • Dividend Yield
  • ADMA N/A
  • PIPR 2.20%
  • EPS Growth
  • ADMA N/A
  • PIPR 106.45
  • EPS
  • ADMA 0.81
  • PIPR 10.24
  • Revenue
  • ADMA $426,454,000.00
  • PIPR $1,525,914,000.00
  • Revenue This Year
  • ADMA $16.18
  • PIPR $18.29
  • Revenue Next Year
  • ADMA $23.92
  • PIPR $13.91
  • P/E Ratio
  • ADMA $22.12
  • PIPR $24.89
  • Revenue Growth
  • ADMA 65.15
  • PIPR 13.20
  • 52 Week Low
  • ADMA $5.88
  • PIPR $183.58
  • 52 Week High
  • ADMA $23.64
  • PIPR $351.80
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 58.84
  • PIPR 32.38
  • Support Level
  • ADMA $15.88
  • PIPR $241.72
  • Resistance Level
  • ADMA $18.25
  • PIPR $258.63
  • Average True Range (ATR)
  • ADMA 1.12
  • PIPR 8.87
  • MACD
  • ADMA 0.25
  • PIPR -2.46
  • Stochastic Oscillator
  • ADMA 86.13
  • PIPR 21.26

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment banking company. Investment banking services include financial advisory services, management of and participation in underwriting, and public finance activities. It generates maximum revenue from Advisory services followed by Equity financing. The company focuses on the following sectors: healthcare; energy; consumer; diversified industrials and services; business services; technology; financial services; agriculture, clean technologies, and renewables, focusing on middle-market clients.

Share on Social Networks: